talazoparib,atezolizumab
pfizer,roche
['lung', 'sclc', 'lcsm,(-blcsm)']
#asco23: results of s1929 trial show patients w small-cell lung cancer w slfn11 expression can benefit from parp inhibitor added to immune checkpoint blockade. #lcsm #sclc
s1929 pi oral pres, sat, june 3, 4:12 pm, hall b1 
SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.